Johnson & Johnson EBITDA 2010-2024 | JNJ

Johnson & Johnson EBITDA for the quarter ending June 30, 2024 was $8.195B, a 6.69% decline year-over-year.

  • Johnson & Johnson 2023 EBITDA was 24.581B, a 9.28% decline from 2022.
  • Johnson & Johnson 2022 EBITDA was 27.095B, a 1.09% increase from 2021.
  • Johnson & Johnson 2021 EBITDA was 26.804B, a 11.5% increase from 2020.

EBITDA can be defined as earnings before interest, taxes, depreciation and amortization.

Johnson & Johnson EBITDA 2010-2024 | JNJ

  • Johnson & Johnson 2023 EBITDA was 24.581B, a 9.28% decline from 2022.
  • Johnson & Johnson 2022 EBITDA was 27.095B, a 1.09% increase from 2021.
  • Johnson & Johnson 2021 EBITDA was 26.804B, a 11.5% increase from 2020.

EBITDA can be defined as earnings before interest, taxes, depreciation and amortization.
Related Stocks
Company NameMarket
Cap
Eli Lilly (LLY)$861.3B
Novo Nordisk (NVO)$592.4B
AbbVie (ABBV)$341.7B
Merck (MRK)$299.6B
AstraZeneca (AZN)$243.5B
Novartis AG (NVS)$236.5B
Pfizer (PFE)$169B
Sanofi (SNY)$144.1B
Innoviva (INVA)$1.2B